Effect Of Ramadhan Fasting On Apolipoprotein B And Small Dense Ldl In Type 2 Diabetes Mellitus Patients
DOI:
https://doi.org/10.51601/ijhp.v4i4.289Abstract
This study's objective was to ascertain how type 2 Diabetes Mellitus patients' apolipoprotein B and small dense LDL were affected by Ramadan fasting. On 19 patients who had been diagnosed with type 2 DM at H. Adam Malik General Hospital Medan, a longitudinal prospective study from the fasting month of Ramadan until the end of the 2015 Ramadan fast was employed as the research methodology. The information was gathered by obtaining blood samples at the start and end of the Ramadan fast, after which the levels of apolipoprotein B and small dense LDL were determined. The T-Test and Wilcoxon tests were then used to assess the data. According to the study's findings, 13 respondents (68.4%) of the 19 patients with type 2 diabetes were men, and their average age was 57.26 years. Apoliprotein B (p=0.0001), small dense LDL (p=0.022), 2-hour PPG DGD (p=0.039), and mean body weight (p0.001) all indicated statistically significant changes. According to the study's findings, type 2 DM patients' apolipoprotein B and small dense LDL are significantly affected by Ramadan fasting.
References
Jaleel MA, Raza SA, Farah Naaz Fathima FN, Jaleel BNF. Ramadan and diabetes: As-Saum (The fasting):
Indian J Endocrinol Metab. 2011 Oct-Dec; 15(4): 268–273
Azizi F,Siahkolah B. Ramadan Fasting and Diabetes Mellitus:Int J Ramadan Fasting Res.1998;2:8-17.
Azizi F (2002) Research in islamic fasting and health.Ann Saudi med 22:186-191
Kamal S, Ahmad QS, Sayedda K, Haque M.Effect of islamic fasting on lipid profile, total protein and albumin
on healthy muslim male subjects of shri ram murti smarak institute of medical sciences, bareilly, uttar
Pradesh:National Journal of medical research.2012 Oct-Dec;2(4):407-410
Alzoghaibi MA, Pandi-Perumal SR, Sharif MM, Bahammam AS.Diurnal Intermittent Fasting during Ramadan:
The Effects on Leptin and Ghrelin Levels: Plos One.2014 maret;9(3):1-7
Sniderman AD, Furberg CD, Keech A et al. Apolipoproteins versus lipids as indices of coronary risk and as
targets for statin treatment. Lancet 2003; 361: 777–80.
Ahmed Adlounia, Noreddine Ghalimb, Rachid Saı¨ lea, Nezha Hdab, Henri-Joseph Parrac, Abdellah
Benslimaneb, Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fasting, Clinica Chimica
Acta Volume 271, Issue 2, 23 March 1998, Pages 179–189
International Journal of Health and Pharmaceutical
Sh.Yarahmadi, B.Larijani, M.H.Bastanhagh, M. Pajouhi, R.Baradar Jalili, F. Zahedi, etal., Metabolic and clinical
effects of Ramadan fasting in patients with type II diabetes, J. Coll. Physicians Surg. Pak. 13 (2003) 329–332.
Khaled BM, Bendahmane M, Belbraouet S. Ramadan fasting induces modifications of certain serum
components in obese women with type 2 diabetes:Saudi Med J.2006;27(1):23-26
Saasa DA, Attou S, Moutadi F, Kassoul S, Italhi M, Kati D. Effect of the Ramadan on the variations of certain
anthropometric and biochemical parameters in type 2diabtec patients treated with medicationsmixture
(biguanides and sulfamides): Advances in Biological Research.2008;2(5-6):111-120
Al-Kirwi INS. Effect of Ramadan fasting on metabolic parameters of type 2 diabetic patients: Iraqi
J.Comm.Med.2009(1);jan:37-39.
Fararjeh MA, Aljamal A, Faris Mo’ez Al-Islam E, Al-Kurd RA, Khalil M, Al-Bustanji Y. Effect of intermittent
fasting on lipid profile and hematological parameters in healthy volunteers in Jordan: Universal Journal of
Medicine and Dentistry.2012;1(10) januari:005-006.
Khafaji HARH, Bener A, Osman M, Al Merri A, Al Suwaidi J. The impact of diurnal fasting during Ramadan
on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients: Vascular Health and Risk
Management.2012;8:7-14.
Shehab A, abdulle A, El Issa A, al Suwaidi J, Nagelkerke N. Favorable changes in lipid profile: the effects of
fasting after Ramadan: Plos One.2012 oktober;8(10):e47615;1-4.
Perkumpulan Endokrinologi Indonesia.Konsensus pengelolaan dan pencegahan diabetes mellitus tipe 2 di
Indonesia 2011
American Diabetes Association. Standards of Medical Care in Diabetes 2013
Kaku K. Pathophysiology of type 2 diabetes and its treatment policy: JMAJ.2010 53(1): 41–46
Chen J, Wildman RP, Hamm LL, Muntner P, Reynolds K, Whelton PK, He J: Third National Health and
Nutrition Examination Survey. Association between inflammation and IR in U.S. nondiabetic adults: results
from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2960–2965.
Eckel RH, Kahn R, Robertson RM, Rizza RA: Preventing cardiovascular disease and diabetes: a call for action
from the American Diabetes Association and the American Heart Association. Circulation 2006,113:2943–2946.
Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J (1979). "Insulin deficiency and insulin resistance
interaction in diabetes:estimation of their relative contribution by feedback analysis from basal plasma insulin
and glucose concentrations.". Metabolism 28 (11):1086–96. doi:10.1016/0026-0495(79)90146- X.PMID 386029.
Méghit Boumédiène Khaled and Slimane Belbraouet, Ramadan Fasting Diet Entailed a Lipid Metabolic
Disorder Among Type 2 Diabetic Obese Women Department of Biology, Faculty of Sciences, Djillali Liabès
University, Sidi-bel-Abbes, Algeria
Mohsen Nematy, Maryam Alinezhad-Namaghi, Masoud Mahdavi Rashed, Mostafa Mozhdehifard, Seyedeh
Sania Sajjadi, Saeed Akhlaghi, Maryam Sabery, Seyed Amir R Mohajeri, Neda Shalaey, Mohsen Moohebat and
Abdolreza Norouz, Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study,
School of Nutrition, Canada, University of Moncton, Moncton, E1A 3E9 Nutrition Journal 2012, 11:69.
G.WALLDIUS&I.JUNGNER,Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease
and targets for lipid-modifying therapy From the King Gustaf V Research Institute and Karolinska Institute,
Stockholm; and AstraZeneca, Mo¨lndal; and CALAB Research and Unit of Clinical Epidemiology, Karolinska
Hospital and Karolinska Institute, Stockholm;Sweden, Journal of Internal Medicine 2004; 255:188–205
Seth S. Martin, Atif N. Qasim, Nehal N. Mehta, Megan Wolfe, Karen Terembula, Stanley Schwartz, Nayyar
Iqbal, Mark Schutta, Roshanak Bagheri, and Muredach P. Reilly, Apolipoprotein B but not LDL Cholesterol Is
Associated With Coronary Artery Calcification in Type 2 Diabetic Whites, DIABETES,VOL.58,AUGUST 2009
Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM: Differences in receptor binding of LDL
subfractions. Arterioscler Thromb16:794–801, 1996
Bjornheden T, Babyi A, Bondjers G, Wiklund O: Accumulation of lipoprotein fractions and subfractions in the
arterial wall, determined in an in vitro perfusion system. Atherosclerosis 123:43–56, 1996
Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J: Influence of plasma lipid and LDL-subfraction
profile on the interaction between low density lipoprotein with human arterial wall
proteoglycans.Atherosclerosis 124:261–271, 1996
Chait A, Brazg RL, Tribble DL, Krauss RM: Susceptibility of small, dense, low-density lipoproteins to oxidative
modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94:350–356,1993
Moeliandari F. Small dense LDL pada familial combined Hyperlipidemia dan penyakit kardiovaskuler,
Informasi Laboratorium Prodia, 2003; No 6: 4–5.
International Journal of Health and Pharmaceutical
Jaleel, M. A., Raza, S. A., Fathima, F. N., & Jaleel, B. N. F. (2011). Ramadan and diabetes: As-Saum (The
fasting). Indian Journal of Endocrinology and Metabolism, 15(4), 268–73. doi:10.4103/2230-8210.85578
Lamarche B,Tchernof A,Moorjani S.Small dense low density lipoprotein particles as a predictor of the risk of
ischemic heart disease in men:prospective results from the Quebec cardiovascular study.Circulation1997: 69–75.
Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman
MJ, Durrington P, Erdine S, Halcox J, Hobbs R, JKjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D for
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the
European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias. Eur
Heart J 2011;32:1769-818.
Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non–high-density lipoprotein cholesterol
and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005;112:3375-83.
Ridker P M, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100,
standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA
;294:326-33.
EI hazmi MAF, AI-Faleh FZ; Effects of Ramadan fasting in the values of haematological and biochemical
parameters. Saudi Med J, 1987; 8:171- 178.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Joseph Partogi Sibarani
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
